clinical trial
phase I
phase 1
phase ii
phase 2
phase 1/2
phase iii
phase 3
late stage
funding
operation warp speed
doses
manufacturing
partner
partnership
vaccine
treatment
immune
immunity
antibody
antibodies
safety
adverse
reaction
beneficial
covid-19
sars-cov-2
coronavirus
AstraZeneca
Takara
Sinovac
Moderna
Walvax
Inovio
BioNTech
GSK
GlaxoSmithKline plc
Pfizer
Dynavax
Novavax